Literature DB >> 9260708

Detection of aberrant crypt foci by magnifying colonoscopy.

T Yokota1, K Sugano, H Kondo, D Saito, K Sugihara, N Fukayama, H Ohkura, A Ochiai, S Yoshida.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9260708     DOI： 10.1016/s0016-5107(97)70212-8

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  16 in total

1.  HD chromoendoscopy coupled with DNA mass spectrometry profiling identifies somatic mutations in microdissected human proximal aberrant crypt foci.

Authors:  David A Drew; Thomas J Devers; Michael J O'Brien; Nicole A Horelik; Joel Levine; Daniel W Rosenberg
Journal:  Mol Cancer Res       Date:  2014-03-20       Impact factor: 5.852

Review 2.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

3.  A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.

Authors:  Daniel L Gillen; Frank L Meyskens; Timothy R Morgan; Jason A Zell; Robert Carroll; Richard Benya; Wen-Pin Chen; Allen Mo; Chris Tucker; Asmita Bhattacharya; Zhiliang Huang; Myra Arcilla; Vanessa Wong; Jinah Chung; Rachel Gonzalez; Luz Maria Rodriguez; Eva Szabo; Daniel W Rosenberg; Steven M Lipkin
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-20

Review 4.  Aberrant crypt foci as microscopic precursors of colorectal cancer.

Authors:  Lei Cheng; Mao-De Lai
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

5.  Aberrant crypt foci: endoscopic assessment and cell kinetics characterization.

Authors:  Pedro Figueiredo; Maria Donato; Marta Urbano; Helena Goulão; Hermano Gouveia; Carlos Sofia; Maximino Leitão; Diniz Freitas
Journal:  Int J Colorectal Dis       Date:  2008-09-04       Impact factor: 2.571

Review 6.  Aberrant crypt foci as precursors in colorectal cancer progression.

Authors:  Frank A Orlando; Dongfeng Tan; Juan D Baltodano; Thaer Khoury; John F Gibbs; Victor J Hassid; Bestoun H Ahmed; Sadir J Alrawi
Journal:  J Surg Oncol       Date:  2008-09-01       Impact factor: 3.454

7.  Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.

Authors:  Akshay K Gupta; Paul Pinsky; Christopher Rall; Matthew Mutch; Sarah Dry; David Seligson; Robert E Schoen
Journal:  Gastrointest Endosc       Date:  2009-06-21       Impact factor: 9.427

Review 8.  Early detection of colon cancer: new tests on the horizon.

Authors:  Akshay K Gupta; Dean E Brenner; D Kim Turgeon
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

9.  The high affinity peroxisome proliferator-activated receptor-gamma agonist RS5444 inhibits both initiation and progression of colon tumors in azoxymethane-treated mice.

Authors:  Weidong Su; Brian M Necela; Kosaku Fujiwara; Shinichi Kurakata; Nicole R Murray; Alan P Fields; E Aubrey Thompson
Journal:  Int J Cancer       Date:  2008-09-01       Impact factor: 7.396

10.  Nanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesions.

Authors:  David A Drew; Thomas Devers; Nicole Horelik; Shi Yang; Michael O'Brien; Rong Wu; Daniel W Rosenberg
Journal:  Proteomics       Date:  2013-04-04       Impact factor: 3.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.